Siddall H, Quint D, Pandya H, Powley W, et al. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the
allergen-induced asthmatic response in a randomized, double-blind,
placebo-controlled experimental medicine study. PLoS One 2020;15:e0240964.
PMID: 33166307